Atlas FDA

Maestro Rechargeable System

FDA premarket approval P130019/S019 · decided 2019-02-15

Approval details

PMA number
P130019
Supplement
S019
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Postapproval Study Protocol
Trade name
Maestro Rechargeable System
Generic name
neuromodulator for obesity
Applicant
Reshape Lifesciences, Inc.
Date received
2018-12-17
Decision date
2019-02-15
Days to decision
60 days
Decision code
APPR
Product code
PIM
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Roseville, MN
Statement
Approval of the revised protocol which includes modification to the follow-up schedule for the post-approval study (PAS) protocol.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.